The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prostate-specific membrane antigen PET response associates with radiographic progression-free survival following stereotactic ablative radiation therapy in oligometastatic castration-sensitive prostate cancer.
 
Philip Sutera
Employment - Catalent (I)
Stock and Other Ownership Interests - Catalent (I); Merck; Pfizer
 
Matthew Deek
No Relationships to Disclose
 
Ozan Cem Guler
No Relationships to Disclose
 
Pervin Hurmuz
No Relationships to Disclose
 
Mehmet Reyhan
No Relationships to Disclose
 
Steven P. Rowe
No Relationships to Disclose
 
William Hrinivich
No Relationships to Disclose
 
Lei Ren
No Relationships to Disclose
 
Ana Ponce Kiess
Research Funding - Bayer; Merck; Novartis
 
Daniel Y. Song
No Relationships to Disclose
 
Ezgi Oymak
No Relationships to Disclose
 
Kenneth J. Pienta
Leadership - CUE Biopharma; Keystone Biopharma
Stock and Other Ownership Interests - CUE Biopharma; Keystone Biopharma; Medsyn Biopharma; Oncopia Therapeutics
Consulting or Advisory Role - Akrevia Therapeutics; CUE Biopharma; GloriousMed Technology
Research Funding - Progenics
Travel, Accommodations, Expenses - CUE Biopharma
 
Martin Pomper
Leadership - Precision Molecular
Stock and Other Ownership Interests - D&D Pharmatech; PlenaryAI
Consulting or Advisory Role - Jubilant Biosys; Precision Molecular; Progenics; Reflexion Medical
Research Funding - Precision Molecular; Roche; Sanofi
Patents, Royalties, Other Intellectual Property - D&D Pharmatech; Progenics
Travel, Accommodations, Expenses - D&D Pharmatech
 
Felix Y Feng
Stock and Other Ownership Interests - Artera
Consulting or Advisory Role - Astellas Pharma; Bayer; BlueStar Genomics; Bristol Myers Squibb; Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; Roivant; SerImmune; Varian Medical Systems
Research Funding - Zenith Epigenetics
 
Gokhan Ozyigit
No Relationships to Disclose
 
Phuoc T. Tran
Honoraria - Reflexion Medical
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Dendreon; GenomeDx; Janssen; Myovant Sciences; Noxopharm; Reflexion Medical; Reflexion Medical; Regeneron
Research Funding - Astellas Pharma (Inst); Bayer Health (Inst); Reflexion Medical (Inst)
Patents, Royalties, Other Intellectual Property - Compounds and Methods of Use in Ablative Radiotherapy. Patent filed 3/9/2012. PCT/US2012/028475. PCT/WO/2012/122471.
Travel, Accommodations, Expenses - Reflexion Medical
 
Ryan Phillips
No Relationships to Disclose
 
Huseyin Cem Onal
No Relationships to Disclose